Unicycive Therapeutics Inc.
Organization details
- Legal name
- Unicycive Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Mountain View
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- UNCY
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001766140
- EIN
- 81-3638692
Board of directors
-
Brigitte Schiller · DirectorSince 2023
-
Gaurav Aggarwal · DirectorSince 2023
-
John L. Ryan · DirectorSince 2023
-
Meredith Manning · DirectorSince 2026
-
Sandeep Laumas · DirectorSince 2023
-
Sara Kenkare-Mitra · DirectorSince 2023
-
Shalabh K. Gupta · Director · CEOSince 2023
Chief executives
Director election results
Annual meeting of June 19, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
92.7%
-
97.9%
Board connections
1 of this board's directors also sit on 1 other board. 1 is in the same sector.
-
Geron Corporation Same sectorvia Gaurav Aggarwal
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 25, 2025 | Gaurav Aggarwal Director | Derivative conversion | +652,900 | — | — |
| Feb 18, 2025 | Gaurav Aggarwal Director | Derivative conversion | +1,400,000 | — | — |
| Oct 9, 2024 | Gaurav Aggarwal Director | Derivative conversion | +5,500,000 | — | — |
| Jul 11, 2023 | Gaurav Aggarwal Director | Derivative conversion | +3,470,152 | — | — |
| Jul 11, 2023 | Jermasek Douglas Officer (EVP of Corporate Strategy) | Option exercise | +104,612 | — | — |
| Jul 11, 2023 | Gupta Pramod Officer (EVP, Pharmaceuticals and BD) | Option exercise | +41,845 | — | — |
| Jul 11, 2023 | Shalabh K. Gupta Director, Officer (CEO) | Option exercise | +104,612 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Unicycive Therapeutics Inc.
Who is the CEO of Unicycive Therapeutics Inc.?
Shalabh K. Gupta is Unicycive Therapeutics Inc.'s CEO.
How many directors are on Unicycive Therapeutics Inc.'s board?
Unicycive Therapeutics Inc.'s board has 7 directors: Brigitte Schiller, Gaurav Aggarwal, John L. Ryan, Meredith Manning, Sandeep Laumas, Sara Kenkare-Mitra and Shalabh K. Gupta.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="unicycive-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.